Position in ARQT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,567,019
+$601,507 QoQ
Shares Held
278,736
+35.7% QoQ
Ownership
0.223%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 91.05210665289019.ToString("F0")%
Shared 0.ToString("F0")%
None 8.94789334710981.ToString("F0")%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,683,576,696 across 351 Biotechnology names. ARQT ranks #159 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in ARQT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,567,019 | 278,736 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,965,512 | 205,424 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,166,308 | 167,974 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,113,234 | 150,730 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,540,702 | 162,449 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $2,570,906 | 184,559 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,592,336 | 171,219 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,267,915 | 136,335 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,398,281 | 141,098 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $3,948,364 | 1,222,404 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $43,871,441 | 8,262,042 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $87,797,848 | 9,212,786 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $100,786,730 | 9,162,430 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $135,259,759 | 9,139,173 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $170,637,603 | 8,929,231 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $164,357,210 | 7,712,680 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $145,559,240 | 7,557,593 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $156,466,955 | 7,544,212 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $180,041,370 | 7,536,265 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $205,513,894 | 7,530,740 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $220,922,468 | 7,636,449 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $184,115,463 | 6,545,164 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $167,841,914 | 5,728,393 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $173,069,023 | 5,723,182 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $170,257,621 | 5,713,343 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||